Health Products

RAN-Zopiclone (2015-09-25)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberBrand nameCompaniesDosage formDIN, NPN, DIN-HIMStrength
487796RAN-Zopiclone
Recalling Firm
Ranbaxy Pharmaceuticals Canada Inc.
200-2680 Matheson Blvd. East
Mississauga
L4W 0A5
Ontario
CANADA
Marketing Authorization Holder
Ranbaxy Pharmaceuticals Canada Inc.
200-2680 Matheson Blvd. East
Mississauga
L4W 0A5
Ontario
CANADA
TabletDIN 02267926Zopiclone 7.5 mg

Introduction

Affected Products

RAN-Zopiclone

Reason

Lot may contain oversized tablets exceeding the maximum recommended daily dose of 7.5 mg

Depth of distribution

Wholesalers
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime